Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121148603 | 12114860 | 3 | F | 201409 | 20160722 | 20160225 | 20160722 | EXP | JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-011919 | BRISTOL MYERS SQUIBB | 87.00 | YR | M | Y | 45.30000 | KG | 20160722 | OT | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121148603 | 12114860 | 1 | PS | SPRYCEL | DASATINIB | 1 | Unknown | 50 MG, UNK | 21986 | 50 | MG | ||||||||
| 121148603 | 12114860 | 2 | C | CALCIUM CARBONATE. | CALCIUM CARBONATE | 1 | Oral | 4.5 G, QD | U | 0 | 4.5 | G | QD | ||||||
| 121148603 | 12114860 | 3 | C | ALFACALCIDOL | ALFACALCIDOL | 1 | Oral | 0.25 ?G, QD | U | 0 | .25 | UG | QD | ||||||
| 121148603 | 12114860 | 4 | C | TRIAZOLAM. | TRIAZOLAM | 1 | Oral | 0.25 MG, QD | U | 0 | .25 | MG | QD | ||||||
| 121148603 | 12114860 | 5 | C | DROXIDOPA | DROXIDOPA | 1 | Oral | 2 G, QD | U | 0 | 2 | G | QD | ||||||
| 121148603 | 12114860 | 6 | C | IMATINIB | IMATINIB | 1 | Unknown | 300 MG, QD | 0 | 300 | MG | QD | |||||||
| 121148603 | 12114860 | 7 | C | IMATINIB | IMATINIB | 1 | Unknown | 600 MG, QD | 0 | 600 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 121148603 | 12114860 | 1 | Chronic myeloid leukaemia |
| 121148603 | 12114860 | 2 | Product used for unknown indication |
| 121148603 | 12114860 | 3 | Product used for unknown indication |
| 121148603 | 12114860 | 4 | Product used for unknown indication |
| 121148603 | 12114860 | 5 | Product used for unknown indication |
| 121148603 | 12114860 | 6 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 121148603 | 12114860 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 121148603 | 12114860 | Cardiotoxicity | |
| 121148603 | 12114860 | Pleural effusion |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 121148603 | 12114860 | 1 | 201408 | 0 |